Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x100px
Financing › Details–Inova Software: investment, 202201 acquisition by Inova


Period Period 2022-01-18
  Predecessor Inova Software–Carlyle: investment, 202107 growth equity investment €60m by CETP IV with Carlyle becoming largest shareholder
Organisations Money taker UG (haftungsbeschränkt)
  Group Inpart (Group)
  Money source Inova Software SAS
  Today Inpart SAS
  Group Inpart (Group)
Products Product
  Product 2 Inova Partnering Platform (SaaS)
Persons Person Toulemonde, Caroline (Inova Software 202201 Chief Strategy Officer)
  Person 2 Eeckhout, Joachim ( Co-Founder)

Inova Software SAS. (1/18/22). "Press Release: Inova Acquires Leading European Biotech News Media Company, Labiotech". Lyon.

Inova, the leading biopharma partnering platform, has acquired Labiotech, an independent news media covering European biotech innovation. This acquisition follows a €60 million investment from global investment firm Carlyle (NASDAQ: CG) in 2021 and reaffirms the strong commitment from NextStage AM, and represents a first-of-its-kind offering for biotechs, academia, and pharmaceutical companies globally.

Inova supports more than 150 global clients, including many of the world’s largest pharmaceutical companies, and is at the forefront of digital transformation in biopharma collaborations. Inova’s flagship product, 'Inova Enterprise’, serves as a collaborative tool used to manage all potential partnerships related to outsourced innovation to laboratories and biotechs, enabling customers to source leads, execute transactions, manage alliances and virtual events. is the leading news website for the biotech industry in Europe. Launched in 2014, it is read by over 100,000 biotech professionals each month and plays a critical role in the industry as a trusted source of information and analysis. The standard of independent journalism and accessible information provided by, ensures biotech professionals can stay informed and collaborate more easily.

Through this acquisition, Inova and Labiotech will partner together to offer the industry a unique space to connect with key players from both sides, remain informed on relevant updates, and manage all their partnering processes in one place. While Labiotech will remain editorially independent in its news selection and production, founder and General Manager, Joachim Eeckhout, will report to Inova’s Chief Strategy Officer, Caroline Toulemonde.

“ We are thrilled to welcome Labiotech into Inova’s team and we are very excited for the year ahead. This partnership will expand our offerings from both sides. We believe in access to information and sharing of knowledge and recognize its importance in a technology driven industry. More importantly, this affiliation will give European scientists a platform to partner and collaborate with top pharmaceutical companies and investors worldwide. We’re building a digital bridge for life science innovation. ”

Gilles Toulemonde
Founder and CEO

“ We founded to fill the gap of information in the European biotech industry and this acquisition gives us the support to go even further in our mission. Labiotech and Inova are two faces of the same coin. On one side, Labiotech provides information so that biotech and pharma companies can discover each other and follow industry-level trends. On the other side, Inova helps them to meet and organize innovation together through their software solutions. The marriage of media and SaaS is very synergetic, and this example applied to life sciences has never been seen before. For the last 7 years, we’ve been uniquely positioned to connect biotechs and biopharma professionals to make them more informed and successful, and I’m looking forward to leading our team through the next chapter of our story. ”

Joachim Eeckout
Founder and General Manager

About Inova

Inova is a cloud-based solution aimed at helping life science companies locate and manage their biopharma opportunities more efficiently. It offers a platform for partnering events, secure licensing and collaboration opportunities, and successful deal making and alliance management. Inova has over 125 employees and is headquartered in Lyon, France, with offices in New York, Denver, and Tokyo. Further information is available at Follow Inova on LinkedIn and Twitter.

About Labiotech

Labiotech is the publishing company of, the leading news website for the biotech industry in Europe. Labiotech has 6 employees and is headquartered in Berlin, Germany.

Follow Labiotech on LinkedIn and Twitter.

Media contacts:

Sarah Issa
Tel: +33 (0) 6 24 86 81 69

Joachim Eeckout
Tel: +49 157 53040778

Record changed: 2024-01-09


Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Inpart (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x300px

» top